1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow DP-R208: new trials by email Literature Review of DP-R208 trials Research Report on DP-R208
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy DP-R208, Candesartan32mg, Rosuvastatin 20mg - Hypertension, Cholesterolemia | Phase 3 | Completed | Alvogen Korea | 219 | 2015-12-01 | 2016-12-26 |
Hypertension (1)
Alvogen Korea (1)
South Korea (1)
Changkyu Park (1)